NCT00516113 - A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

November 30, 2002

Conditions

Premenstrual Dysphoric DisorderPremenstrual Syndrome

Interventions

DRUG

paroxetine

Capsules containing either placebo or paroxetine 20 mg. The treatment start after ovulation and when the subject has experienced premenstrual irritability for 2 days. The dosage is one capsule daily at 8 AM

Trial Locations (1)

SE43180

The Psychiatric clinic, Sahlgrenska University Hospital, Gothenburg